This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When you hear the words “healthcare privateequity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector? In most of the world, healthcare is either government-run or a mixed public/private sector. Are there many private healthcare companies for PE firms to acquire?
Lower margins, in many cases, make these businesses unattractive to all but a small handful of financial investors like privateequity groups, who look to invest, build a company up and then often sell to a larger privateequity group. And the trustee will get in the middle of that decision.”
Carve out tech acquisitions also continued to be attractive to strategic and privateequity buyers, with GTCR’s acquisition of a majority stake in Worldpay from FIS for up to $18.5 Privateequity activity accounted for only 27% of tech M&A in 2023, a six-year low (and a substantial decrease from the 2021 record of 36%).
Together, they will expand and strengthen relationships with privateequity partners that value Intrepid’s core services of M&A, Capital Advisory, Buy-Side Search, and Special Situations and unique capabilities that include access to its corporate parents balance sheet and global relationships, as Japans largest financialinstitution.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content